Triple Hair Group Signs Licensing Agreement for the Brazilian Market with Aché Posted on June 23, 2025 (June 22, 2025) by Pascale Bouchard […] Read More…
Triple Hair Group Strengthens Leadership Team with Appointment of Paul Sowyrda to its Board of Directors Posted on May 28, 2025 (May 28, 2025) by Pascale Bouchard […] Read More…
Triple Hair Group Enters Into Licensing Agreement with Akums for Therapy-07 in India Posted on October 23, 2024 by Pascale Bouchard […] Read More…
Triple Hair Group Receives EMA Approval to Start Phase III Clinical Trials on its Therapy-07 Prescription Drug in Europe Posted on June 19, 2024 (June 19, 2024) by Pascale Bouchard […] Read More…
Triple Hair Group Closes $4 Million Financing Posted on June 3, 2024 by Pascale Bouchard […] Read More…
Triple Hair Wins “Jury’s Choice Award” at Octane Aesthetic Tech Forum Posted on February 12, 2024 (February 12, 2024) by Pascale Bouchard […] Read More…
Triple Hair Group Signs Licensing Agreement for South Korean Market with Mother’s Pharmaceutical Posted on October 17, 2023 (February 15, 2024) by Pascale Bouchard […] Read More…
OpportunitiesNB Article on an interview with our CEO Jean-Phillipe Gravel Posted on July 27, 2023 by Pascale Bouchard […] Read More…
Triple Hair Group receives Health Canada approval to start Phase III clinical trials on its Therapy-07 prescription drug in Canada Posted on June 28, 2023 by Pascale Bouchard […] Read More…
Triple Hair Group consolidates its position as industry leader and innovator for its Therapy-07 prescription drug in the U.S. Posted on June 19, 2023 by Pascale Bouchard […] Read More…